Indiana University School of Medicine researchers received over $243 million in total funding from the National Institutes of Health during federal fiscal year 2023 — a more than $54 million increase over the past five years, or 28%.
With the emergence of promising treatments that slow the cognitive decline of Alzheimer’s disease in patients, there are still questions surrounding side effects of the drugs. An Indiana University School of Medicine researcher is among the few neuroscientists investigating these adverse events, which can cause brain swelling and brain bleeding.
An Indiana University School of Medicine surgeon-scientist is leading a multi-institutional grant investigating the role of the sinus microbiome in chronic rhinosinusitis, an inflammatory disease that causes the lining of the sinuses to swell.
INDIANAPOLIS—Researchers at Indiana University School of Medicine are using a novel approach to hopefully develop a new therapy for glaucoma, a complex disease that eventually leads to blindness, thanks to a new five-year, $2 million R01 grant from the National Eye Institute.
Two researchers with the Indiana University Melvin and Bren Simon Comprehensive Cancer Center and the Richard L. Roudebush Veterans Administration Medical Center have been awarded a three-year, $1 million grant to expand lung cancer screenings to veterans across Indiana.
A five-year, $3.9 million grant will enable Indiana University School of Medicine researchers to explore how allergies and asthma may be passed from mothers to their children, presenting a better understanding of how allergies develop and paving the way for transformative approaches to allergy prevention and management.
IU School of Medicine researchers are taking steps to improve the accessibility and quality of care for adolescents experiencing opioid use disorder (OUD) and other substance use disorders (SUDs), thanks to a new $5 million grant from the National Institute of Health’s Helping to End Addiction Long-Term (HEAL) Initiative.
An Indiana University leukemia physician-scientist has been awarded a $1 million grant from the Leukemia and Lymphoma Society to evaluate a new treatment for an extremely rare and incurable blood cancer.
Two researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center have received a five-year, $2.4 million grant from the National Cancer Institute (NCI) to explore new therapies that target the critical pathways pancreatic tumors use to survive.